Literature DB >> 26622070

Ocular Perfusion Pressure vs Estimated Trans-Lamina Cribrosa Pressure Difference in Glaucoma: The Central India Eye and Medical Study (An American Ophthalmological Society Thesis).

Jost B Jonas1, Ningli Wang2, Vinay Nangia3.   

Abstract

PURPOSE: To test the hypothesis that taking translamina pressure difference into consideration changes associations between ocular perfusion pressure and glaucomatous optic neuropathy.
METHODS: The population-based Central India Eye and Medical Study included 4711 subjects. Ocular perfusion pressure was calculated as follows: ⅔ [diastolic blood pressure + ⅓ × (systolic blood pressure - diastolic blood pressure)] - IOP. Cerebrospinal fluid pressure (mm Hg) was estimated as follows: 0.44 body mass index (kg/m(2)) + 0.16 diastolic blood pressure (mm Hg) - 0.18 × age (years) - 1.91. Translamina pressure difference was IOP minus cerebrospinal fluid pressure.
RESULTS: In multivariate analysis, higher open-angle glaucoma prevalence was associaed with higher IOP (P<.001; odds ratio [OR], 1.19; 95% CI, 1.15, 1.24) or with higher translamina pressure difference (P<.001; OR, 1.15; 95% CI, 1.10, 1.19), but not with ocular perfusion pressure (P<.37). A smaller neuroretinal rim area was correlated with higher IOP (P<.001; standardized coefficient beta -0.09) or larger translamina pressure difference (P<.001; β -0.10), but not with ocular perfusion pressure (P=.26). Greater prevalence of angle-closure glaucoma was associated with higher IOP (P<.001; OR, 1.22; 95% CI, 1.15, 1.28) or higher translamina pressure difference (P<.001; OR, 1.19; 95% CI, 1.13, 1.25) or lower ocular perfusion pressure (P<.04; OR, 0.95; 95% CI, 0.90, 0.996). Correlation coefficients were highest for the association with IOP and lowest for ocular perfusion pressure. A smaller rim area was correlated with higher IOP (P<.001; beta -0.08) and higher translamina pressure difference (P<.001; beta -0.08); rim area and ocular perfusion pressure were not significantly associated (P=.25).
CONCLUSIONS: The present study provides information on the relationship of translamina pressure difference to the development of optic nerve damage in what is presently called glaucoma. It does not provide support of the idea that ocular perfusion pressure plays a major role in the pathogenesis of optic neuropathy.

Entities:  

Mesh:

Year:  2015        PMID: 26622070      PMCID: PMC4635731     

Source DB:  PubMed          Journal:  Trans Am Ophthalmol Soc        ISSN: 0065-9533


  107 in total

1.  Analysis of residuals: criteria for determining goodness-of-fit.

Authors:  M Straume; M L Johnson
Journal:  Methods Enzymol       Date:  1992       Impact factor: 1.600

2.  Intraocular pressure correlated with arterial blood pressure: the beijing eye study.

Authors:  Liang Xu; Han Wang; Yaxing Wang; Jost B Jonas
Journal:  Am J Ophthalmol       Date:  2007-09       Impact factor: 5.258

3.  Body position and cerebrospinal fluid pressure. Part 2: clinical studies on orthostatic pressure and the hydrostatic indifferent point.

Authors:  B Magnaes
Journal:  J Neurosurg       Date:  1976-06       Impact factor: 5.115

4.  Six-year incidence of angle-closure disease in a South Indian population: the Chennai Eye Disease Incidence Study.

Authors:  Lingam Vijaya; Rashima Asokan; Manish Panday; Nikhil S Choudhari; Sathyamangalam Ve Ramesh; Lokapavani Velumuri; Sachi Devi Boddupalli; Govindan T Sunil; Ronnie George
Journal:  Am J Ophthalmol       Date:  2013-09-25       Impact factor: 5.258

5.  The correlation between cerebrospinal fluid pressure and retrolaminar tissue pressure.

Authors:  W H Morgan; D Y Yu; V A Alder; S J Cringle; R L Cooper; P H House; I J Constable
Journal:  Invest Ophthalmol Vis Sci       Date:  1998-07       Impact factor: 4.799

6.  Intraocular pressure changes and ocular biometry during Sirsasana (headstand posture) in yoga practitioners.

Authors:  Mani Baskaran; Krishna Raman; Krishna Kumar Ramani; Joseph Roy; Lingam Vijaya; Sengamedu S Badrinath
Journal:  Ophthalmology       Date:  2006-06-27       Impact factor: 12.079

7.  Influence of cerebrospinal fluid pressure on the lamina cribrosa tissue pressure gradient.

Authors:  D H Shin
Journal:  Invest Ophthalmol Vis Sci       Date:  1995-10       Impact factor: 4.799

8.  Postural variations of the intraocular pressure as measured with the Mackay-Marg tonometer.

Authors:  A Tarkkanen; J Leikola
Journal:  Acta Ophthalmol (Copenh)       Date:  1967

9.  Body mass index has a linear relationship with cerebrospinal fluid pressure.

Authors:  John P Berdahl; David Fleischman; Jana Zaydlarova; Sandra Stinnett; R Rand Allingham; Michael P Fautsch
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-03-15       Impact factor: 4.799

10.  Effect of inverted body position on intraocular pressure.

Authors:  R N Weinreb; J Cook; T R Friberg
Journal:  Am J Ophthalmol       Date:  1984-12-15       Impact factor: 5.258

View more
  4 in total

1.  Linear interactions between intraocular, intracranial pressure, and retinal vascular pulse amplitude in the fourier domain.

Authors:  Anmar Abdul-Rahman; William Morgan; Ying Jo Khoo; Christopher Lind; Allan Kermode; William Carroll; Dao-Yi Yu
Journal:  PLoS One       Date:  2022-06-28       Impact factor: 3.752

2.  Ocular Perfusion Pressure and the Risk of Open-Angle Glaucoma: Systematic Review and Meta-analysis.

Authors:  Ko Eun Kim; Sohee Oh; Sung Uk Baek; Seong Joon Ahn; Ki Ho Park; Jin Wook Jeoung
Journal:  Sci Rep       Date:  2020-06-22       Impact factor: 4.379

3.  Epidemiological Characteristics of Inpatients Undergoing Surgery for Glaucoma at Tianjin Eye Hospital from 2013 to 2017.

Authors:  Jin Yang; Yue Qu; Boai Li; Zelong Zhong; Liukun Shi; Xiaofeng Tian; Rui Wang; Dan Xu; Yufeng Liu
Journal:  J Ophthalmol       Date:  2021-11-08       Impact factor: 1.909

4.  Translaminar Pressure Difference and Ocular Perfusion Pressure in Glaucomatous Eyes with Different Optic Disc Sizes.

Authors:  Natasha F S Cruz; Katia S Santos; Mateus L Matuoka; Niro Kasahara
Journal:  J Ophthalmic Vis Res       Date:  2021-04-29
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.